Cargando…

A Small-Molecule Tankyrase Inhibitor Reduces Glioma Stem Cell Proliferation and Sphere Formation

Evidence suggests that the growth and therapeutic resistance of glioblastoma (GBM) may be enabled by a population of glioma stem cells (GSCs) that are regulated by typical stem cell pathways, including the WNT/β-catenin signaling pathway. We wanted to explore the effect of treating GSCs with a small...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kierulf-Vieira, Kirsten Strømme, Sandberg, Cecilie Jonsgar, Waaler, Jo, Lund, Kaja, Skaga, Erlend, Saberniak, Birthe Mikkelsen, Panagopoulos, Ioannis, Brandal, Petter, Krauss, Stefan, Langmoen, Iver Arne, Vik-Mo, Einar Osland
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352564/ https://www.ncbi.nlm.nih.gov/pubmed/32575464 http://dx.doi.org/10.3390/cancers12061630

Ejemplares similares

Phenotypic and Expressional Heterogeneity in the Invasive Glioma Cells()()
por: Fayzullin, Artem, et al.
Publicado: (2018)

The efficacy of a coordinated pharmacological blockade in glioblastoma stem cells with nine repurposed drugs using the CUSP9 strategy
por: Skaga, Erlend, et al.
Publicado: (2019)

Functional temozolomide sensitivity testing of patient-specific glioblastoma stem cell cultures is predictive of clinical outcome
por: Skaga, Erlend, et al.
Publicado: (2022)

Transcriptional Profiling of Adult Neural Stem-Like Cells from the Human Brain
por: Sandberg, Cecilie Jonsgar, et al.
Publicado: (2014)

Real-world validity of randomized controlled phase III trials in newly diagnosed glioblastoma: to whom do the results of the trials apply?
por: Skaga, Erlend, et al.
Publicado: (2021)

TBIO-18. ESTABLISHING A PIPELINE FOR INDIVIDUALIZED TREATMENT OPTIONS FOR PEDIATRIC BRAIN CANCER
por: Djirackor, Luna, et al.
Publicado: (2020)

Feasibility study of using high-throughput drug sensitivity testing to target recurrent glioblastoma stem cells for individualized treatment
por: Skaga, Erlend, et al.
Publicado: (2019)

Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells
por: Stangeland, Biljana, et al.
Publicado: (2015)

Intertumoral heterogeneity in patient-specific drug sensitivities in treatment-naïve glioblastoma
por: Skaga, Erlend, et al.
Publicado: (2019)

The benefit of complete resection of contrast enhancing tumor in glioblastoma patients: A population-based study
por: Mendoza Mireles, Eduardo Erasmo, et al.
Publicado: (2023)

Aqp 9 and Brain Tumour Stem Cells
por: Fossdal, Guri, et al.
Publicado: (2012)

Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma
por: Vik-Mo, Einar Osland, et al.
Publicado: (2013)

Expansion of Multipotent Stem Cells from the Adult Human Brain
por: Murrell, Wayne, et al.
Publicado: (2013)

Identification of response signatures for tankyrase inhibitor treatment in tumor cell lines
por: Mygland, Line, et al.
Publicado: (2021)

Tankyrase inhibition sensitizes melanoma to PD-1 immune checkpoint blockade in syngeneic mouse models
por: Waaler, Jo, et al.
Publicado: (2020)

The tankyrase-specific inhibitor JW74 affects cell cycle progression and induces apoptosis and differentiation in osteosarcoma cell lines
por: Wessel Stratford, Eva, et al.
Publicado: (2014)

The tankyrase inhibitor G007-LK inhibits small intestine LGR5(+) stem cell proliferation without altering tissue morphology
por: Norum, Jens Henrik, et al.
Publicado: (2018)

Targeting PBK/TOPK decreases growth and survival of glioma initiating cells in vitro and attenuates tumor growth in vivo
por: Joel, Mrinal, et al.
Publicado: (2015)

The Tankyrase Inhibitor OM-153 Demonstrates Antitumor Efficacy and a Therapeutic Window in Mouse Models
por: Brinch, Shoshy A., et al.
Publicado: (2022)

EPCT-15. RAPID EPIGENOMIC CLASSIFICATION OF BRAIN TUMORS ENABLES INTRAOPERATIVE NEUROSURGICAL RISK MODULATION
por: Djirackor, Luna, et al.
Publicado: (2021)

Preclinical Lead Optimization of a 1,2,4-Triazole Based Tankyrase Inhibitor
por: Waaler, Jo, et al.
Publicado: (2020)

Tankyrases: Structure, Function and Therapeutic Implications in Cancer
por: Haikarainen, Teemu, et al.
Publicado: (2014)

Intraoperative DNA methylation classification of brain tumors impacts neurosurgical strategy
por: Djirackor, Luna, et al.
Publicado: (2021)

Tankyrase inhibition ameliorates lipid disorder via suppression of PGC-1α PARylation in db/db mice
por: Wang, Hong, et al.
Publicado: (2020)

Development of a 1,2,4-Triazole-Based Lead Tankyrase Inhibitor: Part II
por: Leenders, Ruben G. G., et al.
Publicado: (2021)

Tankyrase 1 and Tankyrase 2 Are Essential but Redundant for Mouse Embryonic Development
por: Chiang, Y. Jeffrey, et al.
Publicado: (2008)

Short-Term Differentiation of Glioblastoma Stem Cells Induces Hypoxia Tolerance
por: Skjellegrind, Håvard K., et al.
Publicado: (2016)

Ultracentrifugation versus kit exosome isolation: nanoLC–MS and other tools reveal similar performance biomarkers, but also contaminations
por: Skottvoll, Frøydis Sved, et al.
Publicado: (2018)

Novel insight into the function of tankyrase
por: Kim, Mi Kyung
Publicado: (2018)

Whole proteome analysis of human tankyrase knockout cells reveals targets of tankyrase-mediated degradation
por: Bhardwaj, Amit, et al.
Publicado: (2017)

Structural basis of tankyrase activation by polymerization
por: Pillay, Nisha, et al.
Publicado: (2022)

The novel tankyrase inhibitor (AZ1366) enhances irinotecan activity in tumors that exhibit elevated tankyrase and irinotecan resistance
por: Quackenbush, Kevin S., et al.
Publicado: (2016)

Novel CSF1-S100A10 fusion gene and CSF1 transcript identified by RNA sequencing in tenosynovial giant cell tumors
por: PANAGOPOULOS, IOANNIS, et al.
Publicado: (2014)

Tankyrase Inhibitors Stimulate the Ability of Tankyrases to Bind Axin and Drive Assembly of β-Catenin Degradation-Competent Axin Puncta
por: Martino-Echarri, Estefania, et al.
Publicado: (2016)

The telomeric PARP, tankyrases, as targets for cancer therapy
por: Seimiya, H
Publicado: (2006)

Evidence for tankyrases as antineoplastic targets in lung cancer
por: Busch, Alexander M, et al.
Publicado: (2013)

Myeloid leukemia with t(7;21)(p22;q22) and 5q deletion
por: PANAGOPOULOS, IOANNIS, et al.
Publicado: (2013)

Knockdown of NAT12/NAA30 reduces tumorigenic features of glioblastoma-initiating cells
por: Mughal, Awais A., et al.
Publicado: (2015)

Patterns of Invasive Growth in Malignant Gliomas—The Hippocampus Emerges as an Invasion-Spared Brain Region
por: Mughal, Awais A., et al.
Publicado: (2018)

Sjögren syndrome/scleroderma autoantigen 1 is a direct Tankyrase binding partner in cancer cells
por: Perdreau-Dahl, Harmonie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tjf25d1gpesaihj7ptqu3ai82r